A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Clinical trial NCT01682759 · COMPLETED
Trial details
- NCT number
- NCT01682759
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-10
- Primary completion
- 2015-01-26
- Enrollment
- 751
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.